74 related articles for article (PubMed ID: 19840458)
41. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
42. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
[TBL] [Abstract][Full Text] [Related]
43. Depletion of polyamines and increase of transforming growth factor-beta1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts.
Stabellini G; Moscheni C; Gagliano N; Dellavia C; Calastrini C; Ferioli ME; Gioia M
J Periodontol; 2005 Mar; 76(3):443-9. PubMed ID: 15857080
[TBL] [Abstract][Full Text] [Related]
44. c-Myc overexpression and endocrine resistance in breast cancer.
McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
[TBL] [Abstract][Full Text] [Related]
45. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
46. [The Novel Short Isoform of Securin Stimulates the Expression of Cyclin D3 and Angiogenesis Factors VEGFA and FGF2, but Does Not Affect the Expression of MYC Transcription Factor].
Demin DE; Bogolyubova AV; Zlenko DV; Uvarova AN; Deikin AV; Putlyaeva LV; Belousov PV; Mitkin NA; Korneev KV; Sviryaeva EN; Kulakovskiy IV; Tatosyan KA; Kuprash DV; Schwartz AM
Mol Biol (Mosk); 2018; 52(3):508-518. PubMed ID: 29989583
[TBL] [Abstract][Full Text] [Related]
47. Expression of C-Myc mRNA in squamous cell carcinoma of the tongue.
Vora HH; Shah NG; Trivedi TI; Goswami JV; Shukla SN; Shah PM
J Surg Oncol; 2007 Jan; 95(1):70-8. PubMed ID: 17192869
[TBL] [Abstract][Full Text] [Related]
48. [Abnormal expression of programmed cell death 5 gene in multiple myeloma patients].
Bao L; Ruan GR; Lu XJ; Zhang XH; Lu J; Niu JH; Zhang Y; Xie M; Qin YZ; Li LD; Li JL; Liu YR; Chen SS; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):634-7. PubMed ID: 20561417
[TBL] [Abstract][Full Text] [Related]
49. LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma.
Yang X; Ye H; He M; Zhou X; Sun N; Guo W; Lin X; Huang H; Lin Y; Yao R; Wang H
Biochem Biophys Res Commun; 2018 Mar; 498(1):207-213. PubMed ID: 29501744
[TBL] [Abstract][Full Text] [Related]
50. [Expression down-regulation of c-Cbl and Cbl-b genes in peripheral blood mononuclear cells from multiple myeloma patients].
Fang S; Guo X; Leng X; Li B; Niu Y; Chen S; Yang L; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):842-5. PubMed ID: 23948411
[TBL] [Abstract][Full Text] [Related]
51. Investigation of aberrant translational control of c-myc in cell lines derived from patients with multiple myeloma.
Willis AE; Paulin FE; West MJ; Whitney RL
Curr Top Microbiol Immunol; 1997; 224():269-76. PubMed ID: 9308251
[TBL] [Abstract][Full Text] [Related]
52. [Advances Research on C-MYC Proto-oncogene in Multiple Myeloma -Review].
Huang H; Guo WJ; Yao RX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1248-51. PubMed ID: 27531809
[TBL] [Abstract][Full Text] [Related]
53. [Influence of qingdai compound capsule (QDCC) on the expression of c-myc in psoriatic keratinocytes].
Feng J; Xu HQ; Su BS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Mar; 16(3):146-8. PubMed ID: 9208535
[TBL] [Abstract][Full Text] [Related]
54. Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Ernst TJ; Gazdar A; Ritz J; Shipp MA
Blood; 1988 Oct; 72(4):1163-7. PubMed ID: 3048435
[TBL] [Abstract][Full Text] [Related]
55. Appraising myc involvement in high risk myeloma.
Kastritis E; Dimopoulos MA
Leuk Lymphoma; 2015 Mar; 56(3):551-2. PubMed ID: 25257347
[No Abstract] [Full Text] [Related]
56. [Correlation of C-MYC Protein, MDSC and Th17 Cells with Pathogenesis of Myeloma in Different Clinical Stages].
Yan Y; Li YC; Geng CY; Liu C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1881-1886. PubMed ID: 31839054
[TBL] [Abstract][Full Text] [Related]
57. MYC dysregulation in the progression of multiple myeloma.
Misund K; Keane N; Stein CK; Asmann YW; Day G; Welsh S; Van Wier SA; Riggs DL; Ahmann G; Chesi M; Viswanatha DS; Kumar SK; Dispenzieri A; Gonzalez-Calle V; Kyle RA; O'Dwyer M; Rajkumar SV; Kortüm KM; Keats JJ; ; Fonseca R; Stewart AK; Kuehl WM; Braggio E; Bergsagel PL
Leukemia; 2020 Jan; 34(1):322-326. PubMed ID: 31439946
[No Abstract] [Full Text] [Related]
58. [Expression and clinical significance of Bmi-1 gene in multiple myeloma].
Wei W; Zhou F; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):316-8. PubMed ID: 22781727
[No Abstract] [Full Text] [Related]
59. Myc is also the bad guy in myeloma.
Manasanch EE
Leuk Lymphoma; 2016 Nov; 57(11):2485-6. PubMed ID: 27676421
[No Abstract] [Full Text] [Related]
60. [Expression of pituitary tumor transforming gene and C-myc gene in patients with multiple myeloma].
Li DQ; Chen P; Shao JH; Dong XB; Chang YL; Zhao HY; Zhou YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1238-41. PubMed ID: 19840458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
